ロード中...
A Phase II Study of Dasatinib in Patients with Chemo-sensitive Relapsed Small Cell Lung Cancer (CALGB 30602)
INTRODUCTION: SRC is an oncogene with an essential role in the invasiveness and metastasis of solid tumors including small cell lung cancer (SCLC). Dasatinib is a potent inhibitor of SRC as well as other tyrosine kinases. The primary objective of this study was to determine the efficacy of second-li...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2853764/ https://ncbi.nlm.nih.gov/pubmed/20087228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181cee36e |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|